Company Filing History:
Years Active: 2001
Title: **Shouchung Chao: Innovator in Pharmaceutical Formulations**
Introduction
Shouchung Chao, an esteemed inventor based in Taipei, Taiwan, has made significant contributions to the field of pharmaceutical sciences. With a keen focus on enhancing drug delivery systems, Chao has developed innovative dosage forms that aim to improve patient outcomes.
Latest Patents
Chao holds a patent for "Oral cisapride dosage forms with an extended duration." This invention introduces sustained release oral solid dosage forms for cisapride utilizing a multi-particulate system. These formulations are designed to be bioavailable, ensuring efficient blood levels of cisapride over a 24-hour period. The patent details unit dosage forms that comprise multiple substrates containing sustained release cisapride, along with pharmaceutical compositions that include these novel dosage forms.
Career Highlights
Chao is currently associated with the Development Center for Biotechnology, where he continues to push the boundaries of pharmaceutical innovation. His work focuses on developing advanced dosage forms that can enhance drug effectiveness and patient adherence.
Collaborations
In his capacity at the Development Center for Biotechnology, Chao collaborates with fellow researchers and colleagues such as Wen-Pao Tseng and Hui-Fang Chang. Their collective efforts aim to advance pharmaceutical technologies and improve therapeutic options for patients.
Conclusion
Shouchung Chao exemplifies the spirit of innovation within the pharmaceutical industry. Through his groundbreaking patent and collaborative efforts, he contributes to the development of drug formulations that promise better health outcomes for patients. His work not only reflects his dedication but also the potential for future advancements in medication delivery systems.